CASCADER Trademark

Computer hardware for medical and or health use; recorded computer software and computer software using artificial intelligence (AI) and machine learning for medical or health use, namely, for analysing ophthalmic imaging data, for supporting clinical decision-making, for triaging, for diagnosis support, for disease monitoring, for risk stratification and for patient management; downloadable computer software and computer software using artificial intelligence (AI) and machine learning for medical or health use, namely, for analysing ophthalmic imaging data, for supporting clinical decision-making, for triaging, for diagnosis support, for disease monitoring, for risk stratification and for patient management; recorded computer software and computer software using artificial intelligence (AI) and machine learning for modelling of scientific data for research purposes; downloadable computer software and computer software using artificial intelligence (AI) and machine learning for modelling of scientific data for research purposes; recorded computer software and computer software using artificial intelligence (AI) and machine learning for oculomics, namely, for identifying ocular imaging biomarkers and systemic disease risk indicators from ophthalmic images; downloadable computer software and computer software using artificial intelligence (AI) and machine learning for oculomics, namely, for identifying ocular imaging biomarkers and systemic disease risk indicators from ophthalmic images; recorded computer software and computer software using artificial intelligence (AI) and machine learning for detecting, screening, diagnosing and managing eye diseases and systemic disease and health risk indicators detectable and assessable from ophthalmic imaging data, to support the provision of medical and healthcare services and to enable the assessment and analysis of patients for the purpose of clinical decision support and patient management; downloadable computer software and computer software using artificial intelligence (AI) and machine learning for detecting, screening, diagnosing and managing eye diseases and systemic disease and health risk indicators detectable and assessable from ophthalmic imaging data, to support the provision of medical and healthcare services and to enable the assessment and analysis of patients for the purpose of clinical decision support and patient management; recorded software as a medical device (SaMD) for use as a medical instrument for analysing ophthalmic imaging data, identifying ocular imaging biomarkers and systemic disease risk indicators from ophthalmic images and detecting, screening, diagnosing and managing eye diseases and systemic disease and health risk indicators detectable and assessable from ophthalmic imaging data, to support the provision of medical and healthcare services and to enable the assessment and analysis of patients for the purpose of clinical decision support and patient management; downloadable software as a medical device (SaMD) for use as a medical instrument for analysing ophthalmic imaging data, identifying ocular imaging biomarkers and systemic disease risk indicators from ophthalmic images and detecting, screening, diagnosing and managing eye diseases and systemic disease and health risk indicators detectable and assessable from ophthalmic imaging data, to support the provision of medical and healthcare services and to enable the assessment and analysis of patients for the purpose of clinical decision support and patient management; recorded computer operating systems software incorporating artificial neural networks to support the provision of medical and healthcare services and to enable the assessment and analysis of patients for the purpose of clinical decision support and patient management; downloadable computer operating systems software incorporating artificial neural networks to support the provision of medical and healthcare services and to enable the assessment and analysis of patients for the purpose of clinical decision support and patient management

Scientific and technological services, namely, scientific research, clinical research, medical research, data analysis, and technical validation services in the fields of ophthalmology, ophthalmic imaging, medical imaging, digital health and oculomics; research and design services relating to medical imaging software, ophthalmic imaging analysis software, software as a medical device (SaMD), clinical decision support software and oculomics software; research, design and development of computer hardware and software; research, design and development of computer software and computer software using artificial intelligence and machine learning for medical and health use, namely, for analyzing ophthalmic imaging data, for supporting clinical; decision-making, for triaging, for diagnosis support, for disease monitoring, for risk stratification and for patient management, for identifying ocular imaging biomarkers and systemic disease risk indicators from ophthalmic images, for detecting, screening, diagnosing and managing eye diseases and systemic disease and health risk indicators detectable and assessable from opthalmic imaging data, to support the provision of medical and healthcare services and to enable the assessment and analysis of patients for the purpose of clinical decision support and patient management, and for modelling of scientific data for research purposes; scientific and medical research in the field of ophthalmology, ophthalmology diagnostics and oculomics; scientific and medical research into the field of detection, screening, diagnosis and management of eye diseases and systemic disease and health risk indicators detectable and assessable from ophthalmic imaging data; software as a service (SaaS) featuring software for medical and health use, namely for analyzing ophthalmic imaging data, for supporting clinical decision-making, for triaging, for diagnosis support, for disease monitoring, for risk stratification and for patient management; software as a service (SaaS) services featuring software using artificial intelligence and machine learning for medical and health use, namely, for analyzing ophthalmic imaging data, for supporting clinical decision-making, for triaging, for diagnosis support, for disease monitoring, for risk stratification and for patient management; software as a service (SaaS) featuring software for modelling of scientific data for research purposes; and software as a service (SaaS) services featuring software using artificial intelligence and machine learning for modelling of scientific data for research purposes; software as a service (SaaS) featuring software for oculomics, namely, identifying ocular imaging biomarkers and systemic disease risk indicators from ophthalmic images; and software as a service (SaaS) services featuring software using artificial intelligence and machine learning for oculomics, namely, identifying ocular imaging biomarkers and systemic disease risk indicators from ophthalmic images; software as a service (SaaS) featuring software for detecting, screening, diagnosing and managing eye diseases and systemic disease and health risk indicators detectable and assessable from ophthalmic imaging data, to support the provision of medical and healthcare services and to enable the assessment and analysis of patients for the purpose of clinical decision support and patient management; software as a service (SaaS) services featuring software using artificial intelligence and machine learning for detecting, screening, diagnosing and managing eye diseases and systemic disease and health risk indicators detectable and assessable from ophthalmic imaging data, to support the provision of medical and healthcare services and to enable the assessment and analysis of patients for the purpose of clinical decision support and patient management